We recently published 10 Most Undervalued Pharma Stocks To Buy Now. AstraZeneca PLC stands fifth on our list among the most undervalued stocks. AstraZeneca PLC (NASDAQ:AZN), a global biopharmaceutical ...

AstraZeneca AZN -1.94% has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business. The upfront cash ...

AstraZeneca R&D is contributing SEK 100 million and the University of Gothenburg and Region Västra Götaland are each contributing with SEK 25 million. Deeper understanding that meets needs ...

AstraZeneca on Tuesday said it would invest $50billion (£37.1billion) in the US by 2030, creating 'tens of thousands' of highly skilled 'direct and indirect' jobs, while 'powering growth and ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the United States by 2030, it said on Monday, the latest big investment by a pharmaceutical company ...

AstraZeneca ’s AZN 3.11% longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming weight-loss market and aims to ...

AstraZeneca has agreed to acquire U.S.-based vaccine developer Icosavax for $1.1 billion, the companies announced Tuesday, to gain access to experimental vaccines targeting common respiratory ...

AstraZeneca announced plans to invest $50 billion in the U.S., making it the latest company to pour money into the American economy under the Trump administration.

Jenny Nyström, University of Gothenburg, Regina Fritsche-Danielson, AstraZeneca, Helén Eliasson, Region Västra Götaland, and Sara Mazur, Knut and Alice Wallenberg Foundation Metabolism and ...

Tangent AstraZeneca reported $33.7 billion in total revenue through the third quarter and raised its guidance for total revenue this year from a low-to-mid single-digit percentage increase to a ...